Overcoming Challenges and Barriers to Insulin Therapy in Type 2 Diabetes
This activity is supported by an educational grant from sanofi-aventis U.S.
Overcoming Challenges and Barriers to Insulin Therapy in Type 2 Diabetes
Faculty
Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP
Professor of Pharmacy Practice
School of Pharmacy
MCPHS University
Boston, Massachusetts
Donna Horn, RPh, DPh
Adjunct Instructor
Department of Pharmacy Practice
School of Pharmacy
MCPHS University
Boston, Massachusetts
Educational Objectives:
After completing this continuing education program, the participant will be able to:
- Explain barriers for the appropriate use of basal insulin to promote patient adherence to therapy.
- Differentiate between the different pharmacokinetic and pharmacodynamics actions of available and emerging insulin agents.
- Determine the potential role for new and emerging insulin therapies and dosage strengths for treatment of type 2 diabetes mellitus.
- Illustrate insulin administration errors, and explain how effective patient counseling surrounding treatment regimens can reduce errors.
Target audience:
Pharmacists
Type of activity:
Application
Release date:
May 6, 2015
Expiration date:
May 6, 2017
Estimated time to complete activity
: 2.0 hours
Fee:
Free
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-040-H01-P. The activity is available for CE credit through May 6, 2017.
